Dexter, MI, United States of America

Sherrie Rae Tafuri

This inventor holds 4 USPTO granted patents. Top assignee: Warner-Lambert Company. Active years: 1997-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sherrie Rae Tafuri. Retrieved from https://idiyas.com/inventor/sherrie-rae-tafuri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 4

Forward Citations = 213(Granted Patents)


Company Filing History:


Years Active: 1997-1998

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Sherrie Rae Tafuri: Innovator in Vascular Disease Treatment

Introduction

Sherrie Rae Tafuri is a notable inventor based in Dexter, MI (US). She has made significant contributions to the field of medical treatments, particularly in addressing vascular diseases. With a total of 4 patents, her work has garnered attention for its innovative approaches.

Latest Patents

Tafuri's latest patents focus on carboxyalkylethers and their formulations for the treatment of vascular diseases. Her research indicates that dialkyl ethers can lower Lp(a) and triglycerides while elevating HDL-cholesterol. This dual action makes them useful for treating vascular diseases and noninsulin-dependent diabetes mellitus.

Career Highlights

Throughout her career, Tafuri has been associated with Warner-Lambert Company, where she has been able to apply her innovative ideas in a practical setting. Her work has not only advanced scientific understanding but has also contributed to potential therapeutic solutions for patients.

Collaborations

Tafuri has collaborated with esteemed colleagues such as Charles Larry Bisgaier and Paul Leroy Creger. These partnerships have enhanced her research and expanded the impact of her inventions.

Conclusion

Sherrie Rae Tafuri's contributions to the field of vascular disease treatment exemplify the importance of innovation in medicine. Her patents and collaborative efforts continue to pave the way for advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…